Director, Global Real World Evidence (RWE), Oncology

Company: Disability Solutions
Location: Raritan
Posted on: October 19, 2024

Job Description:

Johnson & Johnson is currently seeking a Director, Global Real World Evidence (RWE), Oncology in our Global Commercial Strategy Organization (GCSO) in Raritan, NJ.At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.The Director Global RWE will lead the strategy development and execution of industry leading RWE capabilities and talent development across the Janssen Global Commercial Strategy Organization (GCSO). This individual will work closely with the VP Global RWE and other leaders in GCSO to drive the GCSO transformation to optimize our global go-to-market launch planning strategies through innovative and highly strategic decisions and investments using RWE.Major responsibilities include leveraging their deep industry expertise, and gaining critical cross-functional insight, on opportunities for acceleration of RWE growth across GCSO and putting that strategy into action. Key partnerships include working closely within GCDS, with global medical affairs, market access as well as partnering outside with other departments such as with regional commercial and scientific analytics and US Real World Value & Evidence (RWV&E), Global Epidemiology, J&J Technology Data Sciences, Janssen R&D Data Science, and others.The Director Global RWE will ensure alignment with regional/local RWE stakeholder strategies and contribute to execution as needed. A close working relationship with the medical affairs and market access RWE team will also be essential to support the . This individual will sit on the GCSO Global RWE LT and will interact regularly with other leaders across GCSO and the regional businesses in support of commercial RWE initiatives. This individual will report directly to the VP, GCSO Global RWE, and partner closely with other members in the GCDS.\rResponsibilities:

• \r
• In strong partnership with Global Medical Affairs, Global Market Access and other cross-functional Integrated Evidence Generation Planning (IEG) partners, co-create the RWE strategies. Develop key RWE-based insights on our early pipeline assets to drive global commercial strategies and create a competitive advantage by making better business decisions derived through strategic and patient-centric RWE approaches. Develop the global strategy for the generation and utilization of RWE for our key pipeline assets including, for example, data-driven patient journeys and deep-understanding of unmet medical needs.
• Be a technical leader for the RWE team by defining data and analytics strategies for specific RWE projects across GCSO. Identify and share best practices regarding methods of RWE studies. Further expand the internal Janssen/J&J knowledge and capacity to use evolving methodologies in RWE studies, using various training approaches and best practice sharing. Ensure scientifically and methodologically rigorous analyses are used for observational studies addressing medical, scientific, economic and outcomes research questions.
• Contribute to refining governance processes and contributing to local and global standards in methodologies. Effectively navigate technology, analytical, legal and privacy complexities to achieve objectives.
• Assist in leadership in the global strategy development and execution of industry leading RWE capabilities and talent development across the Janssen GCSO. Interact with and influence senior leadership across global Janssen and J&J on opportunities and investments in RWE that will provide key differentiation for our business growth.
• Work closely within GCSO with Commercial, Medical Affairs and Market Access teams to develop the global strategies for greatest impact and the plans to execute on them. Interface outside of GCSO with the regional businesses, US RWV&E, global epidemiology, R&D, JJT, legal, HCC and others in the development of the RWE strategy and guidelines for evidence generation and usage.
• Show leadership on project teams and set standards of excellence for the team by demonstrating professional expertise, strong work ethic, integrity and professional behavior.
• Lead the coordination and execution of all Evidence Lab across TAs and work with the rest of the RWE team members to build our learnings and strive for continuous improvements of the labs. Support building a global center of excellence in setting up scientific standards for RWE research and co-create and implement key strategic initiatives as designed with critical RWE stakeholders across the organization.
• Responsible for developing and coordinating capability building activities in alignment with the RWE strategy (e.g., building on existing internal resources for developing RWE operational frameworks/tools for conducting RWE research, lead initiatives on RWE competitive Intelligence or developing frameworks for data strategies together with the Global Data, Platforms and Partnerships team, support establishing key strategic partnerships with academic centers, evaluate the impact of RWE research and associated KPIs/metrics, etc) and also lead specific work streams required to deliver on the RWE strategy and priorities
• Work side by side with the CoE Data Science, Digital Health and Data, Platforms and Partnerships teams on joint projects to ensure the optimal combination of RWD/E methodologies and analytics along with AI/ML and Digital solutions are being leveraged to deliver on high value use cases / problems.\r\r

Keywords: Disability Solutions, Vineland , Director, Global Real World Evidence (RWE), Oncology, Executive , Raritan, New Jersey